Vitamin D, Hypertension, Left Ventricular Hypertrophy, and Diastolic Dysfunction

被引:0
作者
Nigwekar S.U. [1 ]
Bhan I. [1 ]
Thadhani R. [1 ]
机构
[1] Division of Nephrology, Massachusetts General Hospital, Boston, MA
关键词
Diastolic blood pressure; Hypertension; Left ventricular hypertrophy; Systolic blood pressure; Vitamin D;
D O I
10.1007/s12170-011-0175-3
中图分类号
学科分类号
摘要
The extra-skeletal effects of vitamin D have been increasingly recognized in the recent years and its effects on blood pressure and cardiac function are areas of active investigation. This article reviews the current state of knowledge about vitamin D with respect to blood pressure and left ventricular hypertrophy. Potential biological mechanisms implicated in linking vitamin D deficiency with hypertension and cardiac dysfunction are outlined along with data from both observational and randomized controlled trials on this topic. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:314 / 322
页数:8
相关论文
共 58 条
[1]  
Teng M., Wolf M., Lowrie E., Ofsthun N., Lazarus J.M., Thadhani R., Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy, N Engl J Med, 349, pp. 446-456, (2003)
[2]  
Teng M., Wolf M., Ofsthun M.N., Lazarus J.M., Hernan M.A., Camargo Jr. C.A., Thadhani R., Et al., Activated injectable vitamin D and hemodialysis survival: a historical cohort study, J Am Soc Nephrol, 16, pp. 1115-1125, (2005)
[3]  
Weishaar R.E., Kim S.N., Saunders D.E., Simpson R.U., Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties, Am J Physiol, 258, (1990)
[4]  
Weishaar R.E., Simpson R.U., Vitamin D3 and cardiovascular function in rats, J Clin Invest, 79, pp. 1706-1712, (1987)
[5]  
Wu J., Garami M., Cheng T., Gardner D.G., 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes, J Clin Invest, 97, pp. 1577-1588, (1996)
[6]  
Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P., 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system, J Clin Invest, 110, pp. 229-238, (2002)
[7]  
Xiang W., Kong J., Chen S., Cao L.P., Qiao G., Zheng W., Liu W., Li X., Gardner D.G., Li Y.C., Et al., Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems, Am J Physiol Endocrinol Metab, 288, (2005)
[8]  
Zhou C., Lu F., Cao K., Xu D., Goltzman D., Miao D., Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice, Kidney Int, 74, pp. 170-179, (2008)
[9]  
Bodyak N., Ayus J.C., Achinger S., Shivalingappa V., Ke Q., Chen Y.S., Rigor D.L., Stillman I., Tamez H., Kroeger P.E., Wu-Wong R.R., Karumanchi S.A., Thadhani R., Kang P.M., Et al., Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals, Proc Natl Acad Sci U S A, 104, pp. 16810-16815, (2007)
[10]  
Woodhouse P.R., Khaw K.T., Plummer M., Foley A., Meade T.W., Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease, Lancet, 19, 343, pp. 435-439, (1994)